AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 25835233
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 tablets (2000 IU/day) for six months
Trial: 22307529
Drug: 0.1% gentamicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1% gentamicin cream
Trial: 19542998
Drug: Esmolol (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esmolol (0.5 mg/kg) during sevoflurane anesthesia
Trial: 19542998
Drug: Esmolol (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esmolol (0.5 mg/kg) during desflurane anesthesia
Trial: 9801975
Drug: High-dose aprotinin
RxNorm normalized name: Aprotinin
DrugBank: Aprotinin (DB06692)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: High-dose aprotinin during orthotopic liver transplantation (OLT)
Trial: 9801975
Drug: High-dose aprotinin
RxNorm normalized name: Aprotinin
DrugBank: Aprotinin (DB06692)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: High-dose aprotinin during cardiac surgery
Trial: 2154316
Drug: Chemotherapy for
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy for nonseminomatous germ cell tumors
Trial: 2154316
Drug: Therapeutic approaches
RxNorm normalized name: Moisturel Therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapeutic approaches (surgery, chemotherapy, surgery plus chemotherapy)
Trial: 842382
Drug: Levodopa treatment
RxNorm normalized name: Levodopa
DrugBank: Levodopa (DB01235)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Levodopa treatment for 6 months
Trial: 30786861
Drug: 12-week moderate-intensity
RxNorm normalized name: risedronate
DrugBank: Risedronic acid (DB00884)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 12-week moderate-intensity exercise program (Borg perceived rating scale 13-14), at least three times weekly; one supervised group training and two home-based sessions
Trial: 28005705
Drug: Distal treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Distal treatment applied mainly in the distal branches beyond the main bifurcation (n = 24)
Trial: 28005705
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment restricted to the main renal artery (n = 21)
Trial: 21665047
Drug: 15-mg modified-release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15-mg modified-release tablet of metoclopramide every 12 hours
Trial: 21665047
Drug: 10-mg immediate-release
RxNorm normalized name: IR-3535
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10-mg immediate-release tablet of metoclopramide every 8 hours
Trial: 14597948
Drug: aspirin plus
RxNorm normalized name: Aspirin Plus Antacid Extra Strength
FDA approved: no
EMA approved: no
PMDA approved: no
Description: aspirin plus clopidogrel
Trial: 10227336
Drug: Albuterol delivered
RxNorm normalized name: Albuterol
DrugBank: Albuterol (DB01001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol delivered via breath-actuated inhaler (Spiros)
Trial: 10227336
Drug: Albuterol delivered
RxNorm normalized name: Albuterol
DrugBank: Albuterol (DB01001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol delivered via MDI (Ventolin)
Trial: 1914371
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg phenylpropanolamine and 250 mg caffeine
Trial: 1914371
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg phenylpropanolamine
Trial: 15082437
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg caffeine
Trial: 29797914
Drug: Catgut implantation
RxNorm normalized name: CATGUT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Catgut implantation at stellate ganglion combined with oral administration of alendronate sodium
Trial: 29797914
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of alendronate sodium alone
Trial: 28319454
Drug: Live attenuated
RxNorm normalized name: mumps, live attenuated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Live attenuated hepatitis A vaccine
Trial: 26151336
Drug: Ingesting 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ingesting 10 g fat
Trial: 26151336
Drug: Ingesting 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ingesting 40 g fat
Trial: 26151336
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (10 g fat)
Trial: 26151336
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (40 g fat)
Trial: 23964055
Drug: 400 g
RxNorm normalized name: Ambi 60 PSE-400 GFN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 g high-glucoraphanin (HG) broccoli
Trial: 23964055
Drug: 400 g
RxNorm normalized name: Ambi 60 PSE-400 GFN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 g standard broccoli
Trial: 23964055
Drug: 400 g
RxNorm normalized name: Ambi 60 PSE-400 GFN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 g peas
Trial: 16546473
Drug: Rosiglitazone (ROS)
DrugBank: Rosiglitazone (DB00412)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rosiglitazone (ROS) 4 mg daily for 12 weeks
Trial: 9381523
Drug: Candoxatrilat (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candoxatrilat (100 mg i.v.)
Trial: 8222497
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of contraceptive pill (250 micrograms levonorgestrel and 50 micrograms ethinyl estradiol)
Trial: 8222497
Drug: Vaginal administration
RxNorm normalized name: Antiinflammatory products for vaginal administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal administration of contraceptive pill (250 micrograms levonorgestrel and 50 micrograms ethinyl estradiol)
Trial: 29961187
Drug: Chromium picolinate
RxNorm normalized name: Chromium Picolinate
DrugBank: Chromium picolinate (DB11255)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chromium picolinate (Cr‐Pic) at 1.2 mg kg‐1
Trial: 29961187
Drug: Chromium picolinate
RxNorm normalized name: Chromium Picolinate
DrugBank: Chromium picolinate (DB11255)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chromium picolinate (Cr‐Pic) at 1.8 mg kg‐1
Trial: 29961187
Drug: Chromium picolinate
RxNorm normalized name: Chromium Picolinate
DrugBank: Chromium picolinate (DB11255)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chromium picolinate (Cr‐Pic) at 1.2 mg kg‐1 and 1.8 mg kg‐1
Trial: 29961187
Drug: Low-protein diet
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-protein diet with 1.8 mg kg‐1 Cr
Trial: 27346880
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (GH) 0.5 mg/day for 6 months
Trial: 19948383
Drug: Oxycodone 10mg
RxNorm normalized name: OXYCODONE 10MG/ACETAMINOPHEN 300MG TAB
DrugBank: Oxycodone (DB00497)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oxycodone 10mg
Trial: 22365897
Drug: Alprazolam 0.5mg
RxNorm normalized name: ALPRAZOLAM 0.5MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alprazolam 0.5mg + Oxycodone 10mg
Trial: 15906783
Drug: Tamsulosin (0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamsulosin (0.4 mg MR o.d.) for 12 weeks
Trial: 10856736
Drug: Milrinone infusion
RxNorm normalized name: Milrinone
DrugBank: Milrinone (DB00235)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Milrinone infusion for 48 hours
Trial: 10856736
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy (placebo infusion for 48 hours)
Trial: 6347152
Drug: Topical oxymetazoline
RxNorm normalized name: oxymetazoline Topical Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical oxymetazoline hydrochloride 0.025%
Trial: 23155956
Drug: Gabapentin 100
RxNorm normalized name: gabapentin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin 100 mg at night and 300 mg orally two hours before surgery
Trial: 1734386
Drug: Erythromycin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin (10 days of oral treatment)
Trial: 1734386
Drug: Mupirocin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mupirocin (10 days of topical treatment)
Trial: 6093182
Drug: Desimipramine (DMI)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desimipramine (DMI) 50 mg IV
Trial: 6093182
Drug: Desimipramine (DMI)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desimipramine (DMI) 25 mg IV
Trial: 6093182
Drug: Chlorimipramine (CI)
RxNorm normalized name: Chlorimipramine
DrugBank: Clomipramine (DB01242)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chlorimipramine (CI) 25 mg IV
Trial: 6093182
Drug: Sulpiride (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulpiride (100 mg IV)
Trial: 6093182
Drug: Diazepam (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam (10 mg IV)
Trial: 29336628
Drug: Dietary supplement
RxNorm normalized name: dietary supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietary supplement containing 178 mg satiereal, 100 mg naringin, and 2,000 IU vitamin D3 daily (SUPP)
Trial: 20454497
Drug: Sildenafil (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil (50 mg dose)
Trial: 17507738
Drug: 50 g/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 g/d of protein
Trial: 17507738
Drug: 100 g/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 g/d of protein
Trial: 17507738
Drug: 200 g/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 g/d of protein
Trial: 17507738
Drug: All protein
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All protein intakes (50 g, 100 g, 200 g)
Trial: 11803082
Drug: TA‐CD therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TA‐CD therapeutic vaccine at 13 microg
Trial: 11803082
Drug: TA‐CD therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TA‐CD therapeutic vaccine at 82 microg
Trial: 11803082
Drug: TA‐CD therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TA‐CD therapeutic vaccine at 709 microg
Trial: 11803082
Drug: TA‐CD therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TA‐CD therapeutic vaccine (all doses combined)
Trial: 12176783
Drug: Primary single-agent
RxNorm normalized name: Sodium primary phosphate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Primary single-agent epirubicin (120 mg/m(2) every 3 weeks for three cycles)
Trial: 9825179
Drug: Coenzyme Q10
RxNorm normalized name: Coenzyme Q10
DrugBank: Ubidecarenone (DB09270)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Coenzyme Q10 (120 mg/d) for 28 days
Trial: 2496977
Drug: Flecainide acetate
RxNorm normalized name: Flecainide Acetate
DrugBank: Flecainide (DB01195)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Flecainide acetate 400 mg
Trial: 337466
Drug: Osmic acid
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Osmic acid treatment
Trial: 7304486
Drug: Bengal gram
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bengal gram dal (50 g carbohydrate)
Trial: 7304486
Drug: Rajmah (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rajmah (50 g carbohydrate)
Trial: 7304486
Drug: Wheat (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wheat (50 g carbohydrate)
Trial: 7304486
Drug: Rice (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rice (50 g carbohydrate)
Trial: 7304486
Drug: Dextrose (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dextrose (50 g carbohydrate)
Trial: 24401239
Drug: Simvastatin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin (20 mg/day) + POMx (1g/day)
Trial: 24401239
Drug: Simvastatin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin (20 mg/day) + placebo
Trial: 22677306
Drug: Diclofenac potassium
RxNorm normalized name: Diclofenac Potassium
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Diclofenac potassium 25 mg liquid capsule
Trial: 22677306
Drug: Diclofenac potassium
RxNorm normalized name: Diclofenac Potassium
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Diclofenac potassium 2 x 12.5 mg tablets
Trial: 18584249
Drug: Mosapride (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mosapride (15 mg by mouth with 50 ml of water three times a day starting on postoperative day 1)
Trial: 18584249
Drug: Control (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (50 ml of water three times a day starting on postoperative day 1)
Trial: 10496192
Drug: Vesnarinone 30
RxNorm normalized name: VESNARINONE
DrugBank: Vesnarinone (DB12082)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vesnarinone 30 mg
Trial: 10496192
Drug: Vesnarinone 60
RxNorm normalized name: VESNARINONE
DrugBank: Vesnarinone (DB12082)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vesnarinone 60 mg
Trial: 10496192
Drug: Vesnarinone (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vesnarinone (30 mg or 60 mg)
Trial: 8929752
Drug: ketamine 6.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ketamine 6.0 mg/kg j.i.
Trial: 8929752
Drug: ketamine 3.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ketamine 3.5 mg/kg j.i.
Trial: 8929752
Drug: ketamine 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ketamine 2.5 mg/kg j.i.
Trial: 27492789
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg propranolol (PRO)
Trial: 24875077
Drug: Dextromethorphan 60
RxNorm normalized name: DEXTROMETHORPHAN 60MG/GG 1200MG SA TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dextromethorphan 60 mg 4 times a day
Trial: 24875077
Drug: Clonidine 0.075
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine 0.075 mg 4 times a day
Trial: 22538793
Drug: Initial case
RxNorm normalized name: brigatinib
DrugBank: Brigatinib (DB12267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Initial case management (comprehensive, individual advice about available treatment possibilities for dementia patients)
Trial: 16142248
Drug: 123I-ioflupane radiopharmaceutical
RxNorm normalized name: 123I-Ioflupane
DrugBank: Ioflupane I-123 (DB08824)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: 123I-ioflupane radiopharmaceutical injected intravenously at a dose of 185 MBq
Trial: 10360450
Drug: Capsaicin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capsaicin (100 ml 1 mmol/l)
Trial: 10360450
Drug: Physiological saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physiological saline (100 ml)
Trial: 7353334
Drug: Aspirin 975
RxNorm normalized name: aspirin 975 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 975 mg every 6 hr, started 22 hr before phenytoin dose and continued for 48 hr
Trial: 7353334
Drug: Aspirin 975
RxNorm normalized name: aspirin 975 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 975 mg every 6 hr
Trial: 19048025
Drug: Fractional dose
RxNorm normalized name: plasma protein fraction Injection [Plasmanate]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fractional dose 1/5 of the meningococcal polysaccharide vaccine
Trial: 19048025
Drug: Fractional dose
RxNorm normalized name: plasma protein fraction Injection [Plasmanate]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fractional dose 1/10 of the meningococcal polysaccharide vaccine
Trial: 19048025
Drug: Full dose
RxNorm normalized name: BayRHo-D Full Dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full dose of the meningococcal polysaccharide vaccine
Trial: 19048025
Drug: Fractional doses
RxNorm normalized name: plasma protein fraction Injection [Plasmanate]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fractional doses (1/5 and 1/10) of the meningococcal polysaccharide vaccine
Trial: 19048025
Drug: All doses
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All doses of the meningococcal polysaccharide vaccine
Trial: 8575589
Drug: Aerosol administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aerosol administration of antipseudomonal antibiotics
Trial: 8575589
Drug: Placebo (nebulized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (nebulized solution)
Trial: 8575589
Drug: Aerosol administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aerosol administration of antipseudomonal antibiotics as adjunct to intravenous therapy
Trial: 8575589
Drug: Aerosol maintenance
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aerosol maintenance treatment with appropriate antibiotic in high enough dosage
Trial: 6109855
Drug: Thrice-weekly isoniazid,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrice-weekly isoniazid, rifampicin, streptomycin, and ethambutol (without pyrazinamide)
Trial: 6109855
Drug: Thrice-weekly isoniazid,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrice-weekly isoniazid, rifampicin, streptomycin, and pyrazinamide
Trial: 6109855
Drug: Thrice-weekly isoniazid,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrice-weekly isoniazid, rifampicin, pyrazinamide, and ethambutol
Trial: 6109855
Drug: Thrice-weekly isoniazid,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrice-weekly isoniazid, rifampicin, pyrazinamide, and streptomycin
Trial: 6109855
Drug: Daily isoniazid,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily isoniazid, rifampicin, pyrazinamide, and ethambutol
Trial: 31397120
Drug: Intratracheal administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intratracheal administration of corticosteroids (IAC)
Trial: 25746670
Drug: 24 or
RxNorm normalized name: Theo-24 Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 24 or 60 weeks of combination antiretroviral therapy (cART)
Trial: 23917585
Drug: Intravenous tissue
RxNorm normalized name: allogeneic processed thymus tissue Drug Implant [Rethymic]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous tissue plasminogen activator (100 mg) or streptokinase (1,500,000 U)
Trial: 11215366
Drug: Human albumin
RxNorm normalized name: Human albumin
DrugBank: Albumin human (DB00062)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Human albumin (5-8 g/l ascites)
Trial: 18476179
Drug: Ampicillin/Sulbactam (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ampicillin/Sulbactam (2 g/1 g, IV every 6 h)
Trial: 18476179
Drug: Cefoxitin (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefoxitin (2 g, IV every 6 h)
Trial: 7792559
Drug: Cefuroxime (thrice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefuroxime (thrice daily until the end of the second postoperative day)
Trial: 25910473
Drug: Naloxone Intranasal
RxNorm normalized name: NALOXONE RESCUE KIT INTRANASAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone Intranasal Delivery System (NXN)
Trial: 23834117
Drug: ETN 50
RxNorm normalized name: ETN
DrugBank: Erythrityl tetranitrate (DB01613)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ETN 50 mg twice weekly
Trial: 23834117
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of NB‐UVB phototherapy and ETN
Trial: 21538218
Drug: Low-level laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-level laser therapy (pulsed infrared laser) and exercise therapy for ten sessions over 2 weeks
Trial: 21538218
Drug: Placebo laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo laser and exercise therapy for ten sessions over 2 weeks
Trial: 10750290
Drug: Bladder filled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bladder filled with 300 ml
Trial: 10750290
Drug: Bladder filled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bladder filled with 200 ml
Trial: 8777274
Drug: 100 ng
RxNorm normalized name: NG
DrugBank: Nitroglycerin (DB00727)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 ng LPS/ml
Trial: 8777274
Drug: Medium doses
RxNorm normalized name: TRIGLYCERIDES,MEDIUM CHAIN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medium doses of LPS (100 ng/ml)
Trial: 8777274
Drug: Low doses
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low doses of LPS (1 ng/ml)
Trial: 2050425
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g cefodizime
Trial: 2050425
Drug: 2 g
RxNorm normalized name: Molds 2 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g cefodizime
Trial: 6342956
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg sodium meclofenamate 3-times daily
Trial: 22829919
Drug: Controls (sulfadoxine-pyrimethamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controls (sulfadoxine-pyrimethamine twice)
Trial: 22829919
Drug: Monthly sulfadoxine-pyrimethamine
RxNorm normalized name: pyrimethamine / sulfadoxine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monthly sulfadoxine-pyrimethamine (SP) among HIV-negative participants
Trial: 22829919
Drug: Monthly sulfadoxine-pyrimethamine
RxNorm normalized name: pyrimethamine / sulfadoxine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monthly sulfadoxine-pyrimethamine and two doses of azithromycin (AZI-SP) among HIV-negative participants
Trial: 9329511
Drug: Naproxen (750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen (750 mg daily for 8 weeks)